FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

ALSO NOTED: FDA expands use of Plavix; Merck touts Fosamax data; and much more...

> The FDA has approved the use of Plavix for certain types of heart attacks. Report

> Merck is touting new data that shows Fosamax helped build bone density in the spines of volunteers using steroids to treat arthritis. Report

> GlaxoSmithKline dropped its bid to patent the AIDS drug Combid in Thailand and India after its move sparked protests on the parts of AIDS advocates. Report

> Poniard Pharmaceuticals has completed enrollment in a Phase II trial for small cell lung cancer. Release

And Finally… Researchers at Duke University Medical Center in Durham have used siRNAs to kill prostate cancer cells in mice. Article

Bookmark and Share
Get Your FREE FierceBiotech Email Newsletter:

More stories about Plavix   Merck   GlaxoSmithKline   Phase II   HIV/AIDS   lung cancer